Immunogenicity and Safety of a Candidate Tuberculosis (TB) Vaccine Given to Healthy Adults in a TB-endemic Region

Clinical trial NCT00600782 · COMPLETED

Trial details

NCT number: NCT00600782
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Tuberculosis (TB)Tuberculosis Vaccines

Start date: 2008-02-05
Primary completion: 2008-12-19
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.